<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Acta Biochim. Pol</journal-id>
<journal-title>Acta Biochimica Polonica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Acta Biochim. Pol</abbrev-journal-title>
<issn pub-type="epub">1734-154X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">12299</article-id>
<article-id pub-id-type="doi">10.3389/abp.2024.12299</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Science archive</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Probing the enzymatic activity and maturation process of the EcAIII Ntn-amidohydrolase using local random mutagenesis</article-title>
<alt-title alt-title-type="left-running-head">Loch et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/abp.2024.12299">10.3389/abp.2024.12299</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Loch</surname>
<given-names>Joanna I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2556922/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x15a;ciuk</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kilichowska</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pier&#xf3;g</surname>
<given-names>Izabela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x141;ukaszczyk</surname>
<given-names>Weronika</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zimowska</surname>
<given-names>Katarzyna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaskolski</surname>
<given-names>Mariusz</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Crystal Chemistry and Crystal Physics</institution>, <institution>Faculty of Chemistry</institution>, <institution>Jagiellonian University</institution>, <addr-line>Krakow</addr-line>, <country>Poland</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Doctoral School of Exact and Natural Sciences</institution>, <institution>Jagiellonian University</institution>, <addr-line>Krakow</addr-line>, <country>Poland</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Bioorganic Chemistry</institution>, <institution>Polish Academy of Sciences</institution>, <addr-line>Poznan</addr-line>, <country>Poland</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Crystallography</institution>, <institution>Faculty of Chemistry</institution>, <institution>Adam Mickiewicz University</institution>, <addr-line>Poznan</addr-line>, <country>Poland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/31488/overview">Grzegorz Wegrzyn</ext-link>, University of Gdansk, Poland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2565818/overview">Jacek Lubkowski</ext-link>, National Institutes of Health (NIH), United States</p>
<p>One reviewer who chose to remain anonymous</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Joanna I. Loch, <email>joanna.loch@uj.edu.pl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>71</volume>
<elocation-id>12299</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>10</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Loch, &#x15a;ciuk, Kilichowska, Pier&#xf3;g, &#x141;ukaszczyk, Zimowska and Jaskolski.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Loch, &#x15a;ciuk, Kilichowska, Pier&#xf3;g, &#x141;ukaszczyk, Zimowska and Jaskolski</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>This report describes a comprehensive approach to local random mutagenesis of the <italic>E. coli</italic> Ntn-amidohydrolase EcAIII, and supplements the results published earlier for the randomization series RDM1. Here, random mutagenesis was applied in the center of the EcAIII molecule, i.e., in the region important for substrate binding and its immediate neighborhood (series RDM2, RDM3, RDM7), in the vicinity of the catalytic threonine triplet (series RDM4, RDM5, RDM6), in the linker region (series RDM8), and in the sodium-binding (stabilization) loop (series RDM9). The results revealed that the majority of the new EcAIII variants have abolished or significantly reduced rate of autoprocessing, even if the mutation was not in a highly conserved sequence and structure regions. AlphaFold-predicted structures of the mutants suggest the role of selected residues in the positioning of the linker and stabilization of the scissile bond in precisely correct orientation, enabling the nucleophilic attack during the maturation process. The presented data highlight the details of EcAIII geometry that are important for the autoproteolytic maturation and for the catalytic mechanism in general, and can be treated as a guide for protein engineering experiments with other Ntn-hydrolases.</p>
</abstract>
<kwd-group>
<kwd>L-asparaginase</kwd>
<kwd>Ntn-hydrolase</kwd>
<kwd>random mutagenesis</kwd>
<kwd>enzyme engineering</kwd>
<kwd>AlphaFold prediction</kwd>
</kwd-group>
<contract-num rid="cn001">2019/03/X/NZ1/00584</contract-num>
<contract-sponsor id="cn001">Narodowe Centrum Nauki<named-content content-type="fundref-id">10.13039/501100004281</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>N-terminal-nucleophile amidohydrolases (Ntn-amidohydrolases) are enzymes that hydrolyze the amide bonds of amino acids, peptides, glycopeptides, and sphingolipids (<xref ref-type="bibr" rid="B9">Linhorst and L&#xfc;bke, 2022</xref>), using an N-terminal residue as the primary nucleophile. Ntn-amidohydrolases are produced as inactive precursors which develop their enzymatic activity in an autocatalytic cleavage maturation process that releases the nucleophilic residue (Thr, Ser, Cys) at the newly formed N-terminus of subunit &#x3b2; (<xref ref-type="bibr" rid="B15">Michalska and Jaskolski, 2006</xref>). The <italic>Escherichia coli</italic> EcAIII protein is an Ntn-amidohydrolase with the L-asparaginase activity (<xref ref-type="bibr" rid="B13">Michalska et al., 2005</xref>). L-asparaginases are a large group of enzymes that convert L-Asn to L-Asp and ammonia. According to the most recent classification, EcAIII is a potassium-independent member of Class 2 L-asparaginases (<xref ref-type="bibr" rid="B10">Loch and Jaskolski, 2021</xref>; <xref ref-type="bibr" rid="B3">da Silva et al., 2022</xref>), formerly called plant-type L-asparaginases (<xref ref-type="bibr" rid="B2">Borek and Jask&#xf3;lski, 2001</xref>).</p>
<p>The catalytic center of EcAIII is made of a threonine triplet: Thr179 (the nucleophile), Thr197, and Thr230. In the close vicinity of the triplet, other residues involved in substrate stabilization are located. Among them, the most important is Arg207, which acts as an anchor for the substrate &#x3b1;-carboxylate group, and Asp210, which stabilizes its amino group (<xref ref-type="fig" rid="F1">Figure 1</xref>). The EcAIII molecule also features a sodium-binding (stabilization) loop, which is important for securing the proper orientation of Thr179 nucleophile (<xref ref-type="bibr" rid="B14">Michalska et al., 2008</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> Overall crystal structure of EcAIII (PDB: 2zal, gray) with product (L-Asp, ball-and-stick) bound in the active site; the violet spheres represent sodium ions coordinated in the stabilization loop. Panels <bold>(B, C)</bold> show detailed views (in different orientations) of the active site with color-coding of the randomization regions (the color code is the same as in Panel <bold>(D)</bold>); randomized residues are in stick representation. <bold>(D)</bold> A fragment of EcAIII sequence with randomization positions and numbers of the randomized residues marked below the sequence; sequence numbers of the Thr triplet are marked in red; the full EcAIII sequence is presented in <xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>.</p>
</caption>
<graphic xlink:href="abp-71-12299-g001.tif"/>
</fig>
<p>As all known Ntn-hydrolases, EcAIII requires a maturation step to develop its enzymatic activity. Upon maturation, the peptide bond between Gly178 and Thr179 is cleaved by the same Thr179 nucleophile (<xref ref-type="bibr" rid="B14">Michalska et al., 2008</xref>). The precursor protein is a homodimer, while the mature form of EcAIII is a dimer of two heterodimers, each comprised of subunit &#x3b1; and subunit &#x3b2;. After the autocleavage process, a flexible linker of &#x223c;20 residues remains at the C-terminal part of subunit &#x3b1;. The linker is naturally disordered and undergoes degradation over time (<xref ref-type="bibr" rid="B9">Linhorst and L&#xfc;bke, 2022</xref>).</p>
<p>Our recent studies of the impact of random substitutions (series RDM1, <xref ref-type="sec" rid="s14">Supplementary Table S1</xref>) on EcAIII performance revealed that initiation of autocatalytic cleavage is a complex and multistep process, highly sensitive to even small changes in protein geometry and hydration pattern near the scissile Gly178-Thr179 bond (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). Following the previous run of local random mutagenesis, we performed further randomization trials to probe how the selected regions of the EcAIII molecule tolerate simultaneous multiple amino acid substitutions. Moreover, we also hoped to identify new EcAIII variant(s) with improved catalytic efficiency (k<sub>cat</sub>) or substrate affinity (K<sub>m</sub>), for potential utilization in leukemia therapy (<xref ref-type="bibr" rid="B16">Tosta P&#xe9;rez et al., 2023</xref>).</p>
<p>In this work, segments of the EcAIII sequence for local random mutagenesis (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="sec" rid="s14">Supplementary Table S1</xref>) were selected on the basis of crystal structure analysis. Residue randomization was carried out in the center of the EcAIII molecule, i.e., in the region important for substrate binding and its immediate neighborhood (series RDM2, RDM3, RDM7), in the vicinity of the catalytic threonine triplet (series RDM4, RDM5, RDM6), in the linker region (series RDM8) and in the sodium-binding loop (series RDM9). Although mutations usually led to inactive precursors, we were still able to identify several factors that affect the enzyme performance. Our report is one of few studies (<xref ref-type="bibr" rid="B7">Kim et al., 2010</xref>; <xref ref-type="bibr" rid="B6">Karamitros and Konrad, 2016</xref>; <xref ref-type="bibr" rid="B17">Xu et al., 2018</xref>; <xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>) describing mutagenetic modification of Ntn-hydrolases.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<p>Random mutagenesis was performed according to the QuikChange protocol with the use of the mutagenic primers listed in <xref ref-type="sec" rid="s14">Supplementary Table S1</xref>. In the naming scheme applied in this work, mutants are labeled as &#x201c;RDMY-X,&#x201d; where X is the ordinal number of a particular bacterial colony that was screened, and Y is the number of the mutagenesis trial (<xref ref-type="sec" rid="s14">Supplementary Table S1</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). All SDS-PAGE gels marked with names of the mutants are presented at the end of <xref ref-type="sec" rid="s14">Supplementary Material</xref> (as <xref ref-type="sec" rid="s14">Supplementary Appendix</xref> &#x2013; raw experimental data).</p>
<p>As a matrix for PCR reaction, the EcAIII sequence cloned to the pET11d (or pMCSG92) vector was used. After PCR reaction, the matrix was digested using <italic>DpnI</italic> enzyme (Thermo Scientific). Products of the PCR reaction were transformed to BL21 (DE3) Gold cells. Clone selection procedure, L-asparaginase activity test in cell lysate, and monitoring of autocleavage were performed according to previously described protocol (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). After monitoring of maturation by SDS-PAGE and testing for activity in cell lysate, several clones (active or inactive) were selected for plasmid DNA isolation and sequencing (Genomed SA, Poland) to check the mutations present.</p>
<p>Large-scale expression and purification of selected variants were performed according to previously described procedures (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>, <xref ref-type="bibr" rid="B12">2023</xref>). L-asparaginase activity of mutants was detected using Nessler method as describes earlier (<xref ref-type="bibr" rid="B4">Janicki et al., 2023</xref>). Structure prediction for selected mutants was made using AlphaFold2 (AF2) (<xref ref-type="bibr" rid="B5">Jumper et al., 2021</xref>) with the utilization of Amber relaxation refinement to assure the correct stereochemistry of the models.</p>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and discussion</title>
<p>The results presented herein are a continuation and complementation of the random mutagenesis report on EcAIII published previously as the RDM1 series (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). The randomization trials RDM2 - RDM9 were performed in eight selected regions of the EcAIII sequence (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="sec" rid="s14">Supplementary Figures S1, S2</xref>). Screening was carried out manually for relatively small numbers of clones (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>). The differences in the numbers of analyzed clones in each series were correlated with the analysis of the SDS-PAGE gels: if in a particular series a small number of clones were capable of autoprocessing, we did not continue the screening.</p>
<p>As the screening process was manual (not in a high-throughput mode), not all clones were submitted to sequencing due to a large number of plasmid isolations that would be too laborious for manual protocol. We decided to carry out sequencing for several clones from each series (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>). The randomization trails allowed us to identify new EcAIII variants with interesting properties and to make several important observations related to the enzymatic activity of EcAIII, as well as to sequence variability observed in bacterial proteins annotated as Ntn-amidohydrolases (<xref ref-type="bibr" rid="B4">Janicki et al., 2023</xref>).</p>
</sec>
<sec id="s4">
<title>Role of residues 210 and/or 211 (RDM2 series) in EcAIII activity</title>
<p>In the RDM1 mutagenesis trial, four residues at the substrate binding site, namely, Gly206, Arg207, Asp210, and Ser211, were randomized (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). In the RDM1 series 64 new EcAIII variants were analyzed. Most of them were not cleaved into subunits, and those which were processed did not exhibit L-asparaginase activity. In the RDM1 variants processed to subunits &#x3b1; and &#x3b2; (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>), L-Asn hydrolysis was abolished by the absence of Arg207, which is crucial for substrate binding (<xref ref-type="fig" rid="F1">Figure 1</xref>). In order to analyze the behavior of new variants with intact Arg207 (and Gly206), we decided to run the mutagenesis trial RDM2, in which only Asp210 and Ser211 were randomized (<xref ref-type="sec" rid="s14">Supplementary Table S1</xref>).</p>
<p>Screening of 33 clones of the RDM2 series showed that only 11 variants were cleaved into subunits, and among them only eight retained the L-asparaginase activity (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>). Sequencing revealed that six of the active clones had the wild type (WT) sequence of EcAIII, while the two other active clones carried the mutations D210A/S211P (RDM2-25) and D210P (RDM2-27) (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>). We also found in the RDM2 series three clones that were processed to subunits but did not show L-asparaginase activity during screening. We sequenced two of them, and identified the following mutations: D210A (RDM2-17) and D210A/S211V (RDM2-32) (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>).</p>
<p>Although variants RDM2-25 and RDM2-27 were active, they had a very slow autoproteolysis rate. These observations indicate that the absence of Asp210 and/or Ser211 significantly slows down the maturation process. Although residues 210 and 211 do not seem to be directly involved in autoprocessing, as a polar residues they are part of an H-bond framework that assures the correct positioning of water molecules w3, w4, and w5 near the Gly178-Thr179 scissile bond, as visible in the crystal structure (<xref ref-type="bibr" rid="B14">Michalska et al., 2008</xref>) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Although the AlphaFold2 models do not include water molecules, comparison of the predicted structures of mutants RDM2-25, RDM2-27, RDM2-17 and RDM2-32, and the crystal structure of the EcAIII precursor (PDB: 3c17) shows that in the absence of side chains Asp210 and/or Ser211 the correct network of water-mediated H-bonds near the nucleophilic Thr179 cannot be formed (<xref ref-type="fig" rid="F2">Figure 2A</xref>). These observations can explain the slow autoproteolysis rate of the RDM2 mutants, as well as the low enzymatic performance, as Asp210 is also involved in substrate stabilization.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>AF2-predicted structures of the new EcAIII variants. <bold>(A)</bold> Superposition of the RDM2-25 mutant (light pink) on the EcAIII precursor (PDB: 3c17, gray); water molecules (red spheres) present in the precursor structure are H-bonded (gray dashed lines) to Asp210 and Ser211; due to the mutations, this network of H-bonds is perturbed in the RDM2-25 mutant. <bold>(B)</bold> Superposition of the EcAIII structure (PDB: 2zal, gray) with bound L-Asp (black sticks) and the RDM3-9 mutant (dark green); the presence of Arg209 in the mutant affects the position of Arg207. <bold>(C)</bold> Structural changes in variant RDM3-11 (dark green); the side chain of Gln209 blocks the space reserved for the &#x3b1;-carboxylate group of the L-Asp substrate (black sticks, PDB:2zal). <bold>(D)</bold> Superposition of the RDM3-34 model (green) and WT EcAIII (PDB: 2zal; gray); there are no significant conformational changes. <bold>(E)</bold> Superposition of WT EcAIII (PDB: 2zal, gray) and the predicted model of mutant RDM7-12 (pink); the mutations resulted in atomic shifts and the formation of new H-bonds (red dotted lines), not present in the WT structure. <bold>(F)</bold> Superposition of the predicted structure of the EcAIII precursor (gray) and model of the RDM8-15 mutant (light green); major conformational changes were induced by the presence of Pro174 and Lys173; new H-bonds are marked by red dotted lines.</p>
</caption>
<graphic xlink:href="abp-71-12299-g002.tif"/>
</fig>
<p>For the active mutants RDM2-25 and RDM2-27, large-scale expression and purification were carried out. We observed that only about &#x223c;50% of the RDM2-25 and RDM2-27 mutant proteins were processed into subunits after 48&#xa0;h. When autoprocessing progressed, we observed the development of L-asparaginase activity of variants RDM2-25 and RDM2-27. As it was impossible to separate the populations of mature and immature EcAIII molecules, we were not able to determine the kinetic parameters for preparations of partially cleaved proteins.</p>
<p>The data above suggest that mutations at positions 210 and 211 significantly reduce the autoprocessing rate, but mature variants develop L-asparaginase activity. On the other hand, reported earlier variants from the RDM1 series carrying similar mutations, e.g., RDM1-3, RDM1-12 or RDM1-29, did not exhibit any L-asparaginase activity at all (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). However, in the RDM1 mutants the Arg207 residue was absent, while the RDM2 mutants have intact Arg207 required as an anchor for the &#x3b1;-carboxylate group of the substrate. These observations indicate that the presence of Arg207 is absolutely necessary to maintain substrate affinity, while stabilization of the amino group of the substrate by a H-bond to Asp210 plays a less important role in substrate positioning.</p>
</sec>
<sec id="s5">
<title>Random mutagenesis near the substrate binding site (RDM3 and RDM7)</title>
<p>For the RDM3 series, the SDS-PAGE analysis showed that most of the mutants were not cleaved into subunits. The only clones that were mature and active, RDM3-12 and RDM3-19, had sequence identical to WT EcAIII. We also made attempts to sequence several other immature RDM3 clones. Unfortunately, sequencing was successful only for three mutants (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>): RDM3-9, RDM3-11, and RDM3-34. These three variants were produced at large scale and purified. Although at the screening stage we did not observe autoproteolysis, the large-scale purification revealed a very slow maturation process. Nevertheless, RDM3-9 and RDM3-11, remained enzymatically inactive, while variant RDM3-34 developed L-asparaginase activity. The predicted AF2 model of this variant did not reveal any significant conformational changes (<xref ref-type="fig" rid="F2">Figure 2D</xref>), therefore, the reduced autoproteolytic efficiency of RDM3-34 has unknown origin.</p>
<p>Screening of the RDM3 mutants indicated that simultaneous mutations in the close neighborhood of Arg207 (positions 208, 209, 211, 212) is usually fatal for the catalytic activity of EcAIII because of conformational changes leading to incorrect positioning of the Arg207 side chain in the active site. In the RDM3 trial we randomized the highly conserved Gly209, while the rest of the mutated residues have only moderate or low conservation (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>). These observations indicate that Gly209 is important for maintaining the correct geometry of the active site. Gly209 is located very close to Arg207 and incorporation of residues with large side chains, such as Arg209 (in RDM3-9) or Gln209 (in RDM3-11) results in a positional shift of Arg207. An AF2 model of the RDM3-9 variant revealed that Arg209 and His211 strongly affect the position of Arg207, making substrate binding ineffective (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The predicted structure of mutant RDM3-11 reveled that Gln209 disturbs substrate binding by affecting its positioning (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p>
<p>Most of the RDM7 clones, with randomization introduced at positions Pro212, Leu213, Gly217 and Cys218 (<xref ref-type="fig" rid="F1">Figure 1</xref>), retained the ability to mature, but they lost their L-asparaginase activity. Most of active RDM7 clones (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>) turned out after sequencing to be WT EcAIII. The predicted structure of inactive mutant RDM7-12 revealed a positional shift of the entire 207&#x2013;217 loop, resulting in the formation of new H-bonds, the most important of which links Asp210 and Thr179 (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Such an interaction most probably disturbs substrate binding and affects the nucleophilic character of Thr179.</p>
<p>In the RDM7 series we detected a high proportion of WT sequences. A simple explanation might be an ineffective digestion of the PCR matrix by <italic>DpnI</italic>. However, we rather exclude this possibility as we always run control transformations in parallel. Another explanation might be that degenerated RDM7 primers with WT sequence were annealed in the PCR reaction to the DNA matrix with similar frequency as the degenerated oligonucleotides with non-complementary sequences. This observation suggest that the efficiency of random mutagenesis depends on the DNA sequence itself. In some (rare) cases, when it is not possible to produce new variants using only degenerated primers, other mutagenic approaches must be considered.</p>
</sec>
<sec id="s6">
<title>Mutagenesis in conserved sequence regions (RDM4, RDM5, RDM6 and RDM9)</title>
<p>SDS-PAGE analysis of clones from the RDM4, RDM5, RDM6 and RDM9 series (<xref ref-type="sec" rid="s14">Supplementary Table S1</xref>) revealed that in most cases the new EcAIII variants were incapable of splitting themselves into the &#x3b1; and &#x3b2; subunits. Absence of L-asparaginase activity was observed for all clones of RDM4 series. Plasmid sequencing revealed that selected clones in the RDM5 and RDM6 series that were active had the native WT EcAIII sequence (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>). In series RDM4, RDM5 and RDM6, sequence randomization took place in the close vicinity of the conserved region of the threonine triplet (Thr179, Thr197, Thr230; <xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>). Mutants of the RDM9 series possessed random mutations in the conserved region of sodium-binding (stabilization) loop (Glu61, Cys63, Phe66, Ala68). In this series, the one active variant had sequence identical to WT protein (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>).</p>
<p>These findings indicate that random mutagenesis in the highly conserved fragments of the sequence is ineffective, and it should be avoided or replaced by rational site-directed mutagenesis. However, our recent analysis of residue conservation near the catalytic triplet and the stabilization loop (<xref ref-type="bibr" rid="B4">Janicki et al., 2023</xref>) revealed that in bacterial EcAIII orthologs, substitutions in the Thr triplet and its close vicinity are possible but very rare. For example, the most variable position near Thr179 corresponds to Met177 in EcAIII sequence, which in other proteins can be substituted by Phe, His or Tyr, while the most mutation-prone position in the stabilization loop is Cys63 which can be replaced by Asp, Asn or Ser (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>).</p>
</sec>
<sec id="s7">
<title>Mutagenesis within the variable linker region (RDM8)</title>
<p>It would seem that the chance of obtaining functional EcAIII variants via random local mutagenesis depends on the sequence element that is randomized: the more conserved the designated sequence fragment (associated with a particular function), the lower the probability of obtaining functional clones. From this point of view, the most promising segment is the least-conserved fragment of the EcAIII sequence, namely the flexible Glu159-Gly178 linker immediately preceding the nucleophilic Thr179 (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>). The linker does not participate in substrate binding and L-Asn hydrolysis of the mature enzyme. The role of the linker in autoproteolysis is not clear; however, recently we reported that correct positioning of the linker is essential for efficient autocleavage of the scissile Gly178-Thr179 bond (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>).</p>
<p>The entire linker of &#x223c;20 residues is usually not fully visible in the electron density maps, suggesting high mobility or progressive digestion. As the only available experimental model of EcAIII with part of the linker visible (residues 165&#x2013;178) is the crystal structure of the T179A mutant (PDB: 3c17) (<xref ref-type="bibr" rid="B14">Michalska et al., 2008</xref>), we attempted to generate AF2 models of unprocessed EcAIII. The AF2 predicted conformation of the linker was significantly different from the 3c17 crystal structure. That structure of the inactive T179A mutant showed that residues Glu173 and Lys176 might be important for the stabilization of the scissile bond (which is a part of the linker), as Lys176 is H-bonded to Glu234 and Glu173 forms a salt bridge with Arg149 (<xref ref-type="sec" rid="s14">Supplementary Figure S3</xref>). These interactions were absent in the predicted model of immature WT EcAIII. Instead, we observed an H-bond between the main chain carbonyl O atom of Glu173 and nitrogen of Lys176 (<xref ref-type="sec" rid="s14">Supplementary Figure S3</xref>), as well as an H-bond between the side chains of these residues.</p>
<p>In the RDM8 series we randomized four residues: Glu173, Lys174, Lys176 and Met177, from the linker (<xref ref-type="sec" rid="s14">Supplementary Table S1</xref>). Sequencing revealed that in the RDM8 trial four out of the seven active variants had WT sequence (<xref ref-type="sec" rid="s14">Supplementary Table S2</xref>). However, clones RDM8-6 and RDM8-15 (and RDM8-17) carried mutations (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>). SDS-PAGE analysis showed that in variants RDM8-6 and RDM8-15 autoprocessing was rather slow, however, ultimately the proteins were converted to mature &#x3b1;&#x3b2; subunits and attained their L-asparaginase activity (as the active site region was not mutated). Variant RDM8-6 carried four mutations: E173I/K174Q/K176A/M177I. The AF2 model suggested that the K174Q substitution may lead to the creation of new H-bonds between Gln174, Gln152 and Gln19 (<xref ref-type="sec" rid="s14">Supplementary Figure S3</xref>). According to the prediction, substitutions K174Q and E173I may result in a flip of the 171&#x2013;173 side chains, affecting the C&#x3b1; backbone trace of the linker.</p>
<p>For the RDM8-15 variant with the E173L/K174P/K176E/M177K mutations, the AF2 model suggested that significant conformational changes may be introduced in the linker by the presence of Glu176, H-bonded to Arg149 and Gln152, and by Lys177, H-bonded to Ser274 (<xref ref-type="fig" rid="F2">Figure 2F</xref>), as these interactions are absent in the AF2 model of the WT protein. According to the AF2 model, the substitution K174P of RDM8-15 also contributes to the conformational changes of the linker. The conformational changes in the linker region analyzed in this section may potentially reduce autoproteolysis rate by hampering proper orientation of the Gly178-Thr179 scissile bond for nucleophilic attack.</p>
<p>The results of mutagenesis in the linker region show that by modifying this part of the EcAIII sequence one can tune the efficiency of autoproteolysis without &#x201c;touching&#x201d; the active site. This might be important for designing new EcAIII variants with controlled maturation process. Also, designing EcAIII mutants with impaired autoproteolytic activity might be useful for crystallographic modeling of the intact linker structure, as an important step towards the elucidation of the mechanism of autoproteolytic activation.</p>
</sec>
<sec sec-type="conclusion" id="s8">
<title>Conclusion</title>
<p>This report describes a comprehensive approach to random mutagenesis of EcAIII and is a sequel to a previously published work (<xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>). Our studies reveled that most of the new EcAIII variants had abolished or significantly reduced rate of autoprocessing, and were in consequence devoid of L-asparaginase activity. In this respect, we have demonstrated that local random mutagenesis of the EcAIII sequence is rather ineffective for designing better enzymes with increased substrate affinity. The problem lies not in the randomization itself, but is rooted in the biochemistry of Ntn-amidohydrolases. These enzymes are produced as inactive precursors and it is usually difficult to predict if the introduced mutations will affect the maturation process only, or L-Asn hydrolysis as well. Even if a given substitution could be beneficial for the ultimate substrate hydrolysis, this effect may not be observed if the same mutation is fatal to enzyme maturation. The only way to avoid such problems is to use circularly permutated genes for Ntn-amidohydrolase mutagenesis. This approach has been used only once, for the human HsAIII enzyme (<xref ref-type="bibr" rid="B8">Li et al., 2012</xref>).</p>
<p>We also predicted the role of several residues in the proper orientation of the linker and the scissile bond for autoprocessing. Moreover, we generated genes of several new active and inactive EcAIII variants that enrich the available library of EcAIII mutants (<xref ref-type="bibr" rid="B14">Michalska et al., 2008</xref>; <xref ref-type="bibr" rid="B11">Loch et al., 2022</xref>; <xref ref-type="bibr" rid="B4">Janicki et al., 2023</xref>). We believe that our randomization studies will help to better understand the catalytic properties of Class 2 L-asparaginases and will guide further engineering experiments with other Ntn-amidohydrolases as well as mechanistic studies (<xref ref-type="bibr" rid="B1">Andjelkovic et al., 2023</xref>) of the new Ntn-hydrolases.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s9">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s14">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s10">
<title>Ethics statement</title>
<p>The studies conducted with the use of Genetically Modified Microorganism (GMM) were reviewed and approved by commission on GMM at the Ministry of Climate and Environment (Poland).</p>
</sec>
<sec id="s11">
<title>Author contributions</title>
<p>JIL designed experiments and coordinated the experimental work, carried out mutagenesis, clone screening (RDM3, RDM7), structure modelling, data analysis and wrote the manuscript. AS performed large scale protein expression and activity tests for purified enzymes. MK performed mutagenesis and clone screening of the RDM8 series, carried out structure modelling and participated in manuscript preparation. IP performed clone screening of the RDM2, RDM3 and RDM9 series. WL performed clone screening of the RDM2 series and analyzed the data. KZ performed clone screening of the RDM4, RDM5 and RDM6. MJ analyzed the results and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="s12">
<title>Funding</title>
<p>Work supported by National Science Centre (Poland) grants: 2020/38/E/NZ1/00035 (Sonata Bis) and 2019/03/X/NZ1/00584 (Miniatura).</p>
</sec>
<sec sec-type="COI-statement" id="s13">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>We thank Aleksandra Kusior and Agnieszka Klonecka for help with clone screening and large-scale protein expression.</p>
</ack>
<sec id="s14">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontierspartnerships.org/articles/10.3389/abp.2024.12299/full#supplementary-material">https://www.frontierspartnerships.org/articles/10.3389/abp.2024.12299/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andjelkovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zinovjev</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ramos-Guzm&#xe1;n</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Ruiz- Pern&#xed;a</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Tu&#xf1;&#xf3;n</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Elucidation of the active form and reaction mechanism in human asparaginase type III using multiscale simulations</article-title>. <source>J. Chem. Inf. Model.</source> <volume>63</volume>, <fpage>5676</fpage>&#x2013;<lpage>5688</lpage>. <pub-id pub-id-type="doi">10.1021/ACS.JCIM.3C00900</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borek</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jask&#xf3;lski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Sequence analysis of enzymes with asparaginase activity</article-title>. <source>Acta Biochim. Pol.</source> <volume>48</volume>, <fpage>893</fpage>&#x2013;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.18388/abp.2001_3855</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Doonan</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Pessoa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>P. F.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Structural and functional diversity of asparaginases: overview and recommendations for a revised nomenclature</article-title>. <source>Biotechnol. Appl. Biochem.</source> <volume>69</volume>, <fpage>503</fpage>&#x2013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1002/BAB.2127</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janicki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>&#x15a;ciuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zielezinski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ruszkowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ludwik&#xf3;w</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karlowski</surname>
<given-names>W. M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>The effects of nature-inspired amino acid substitutions on structural and biochemical properties of the <italic>E. coli</italic> L-asparaginase EcAIII</article-title>. <source>Protein Sci. a Publ. Protein Soc.</source> <volume>32</volume>, <fpage>e4647</fpage>. <pub-id pub-id-type="doi">10.1002/PRO.4647</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jumper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pritzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Figurnov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ronneberger</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume>, <fpage>583</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karamitros</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Konrad</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Fluorescence-activated cell sorting of human L-asparaginase mutant libraries for detecting enzyme variants with enhanced activity</article-title>. <source>ACS Chem. Biol.</source> <volume>11</volume>, <fpage>2596</fpage>&#x2013;<lpage>2607</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.6b00283</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Kyeong</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A genetic circuit system based on quorum sensing signaling for directed evolution of quorum-quenching enzymes</article-title>. <source>ChemBioChem</source> <volume>11</volume>, <fpage>1748</fpage>&#x2013;<lpage>1753</lpage>. <pub-id pub-id-type="doi">10.1002/CBIC.201000033</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Yogesha</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chantranupong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Uncoupling intramolecular processing and substrate hydrolysis in the N-terminal nucleophile hydrolase hASRGL1 by circular permutation</article-title>. <source>ACS Chem. Biol.</source> <volume>7</volume>, <fpage>1840</fpage>&#x2013;<lpage>1847</lpage>. <pub-id pub-id-type="doi">10.1021/cb300232n</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linhorst</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>L&#xfc;bke</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The human ntn-hydrolase superfamily: structure, functions and perspectives</article-title>. <source>Cells</source> <volume>11</volume>, <fpage>1592</fpage>. <pub-id pub-id-type="doi">10.3390/CELLS11101592</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loch</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Jaskolski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Structural aspects of L-asparaginases - a growing family with amazing diversities</article-title>. <source>IUCrJ</source> <volume>8</volume>, <fpage>514</fpage>&#x2013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1107/S2052252521006011</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loch</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Klonecka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>K&#x105;dzio&#x142;ka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bonarek</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barciszewski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Imiolczyk</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Structural and biophysical studies of new L-asparaginase variants: lessons from random mutagenesis of the prototypic <italic>Escherichia coli</italic> ntn-amidohydrolase</article-title>. <source>Acta Crystallogr. Sect. D. Struct. Biol.</source> <volume>78</volume>, <fpage>911</fpage>&#x2013;<lpage>926</lpage>. <pub-id pub-id-type="doi">10.1107/s2059798322005691</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loch</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Worsztynowicz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sliwiak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grzechowiak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Imiolczyk</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pokrywka</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Rhizobium etli has two L-asparaginases with low sequence identity but similar structure and catalytic center</article-title>. <source>Acta Crystallogr. Sect. D. Struct. Biol.</source> <volume>79</volume>, <fpage>775</fpage>&#x2013;<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1107/s2059798323005648</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Brzezinski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jaskolski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Crystal structure of isoaspartyl aminopeptidase in complex with L-aspartate</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>28484</fpage>&#x2013;<lpage>28491</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M504501200</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hernandez-Santoyo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jaskolski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The mechanism of autocatalytic activation of plant-type L-asparaginases</article-title>. <source>J. Biol. Chem.</source> <volume>283</volume>, <fpage>13388</fpage>&#x2013;<lpage>13397</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M800746200</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jaskolski</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Structural aspects of L-asparaginases, their friends and relations</article-title>. <source>Acta Biochim. Pol.</source> <volume>53</volume>, <fpage>627</fpage>&#x2013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.18388/abp.2006_3291</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosta P&#xe9;rez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Herrera Bel&#xe9;n</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Letelier</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Calle</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pessoa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Far&#xed;as</surname>
<given-names>J. G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>L-asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: A comprehensive review</article-title>. <source>Med. Oncol.</source> <volume>40</volume>, <fpage>150</fpage>. <pub-id pub-id-type="doi">10.1007/s12032-023-02014-9</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Directed evolution of a penicillin V acylase from Bacillus sphaericus to improve its catalytic efficiency for 6-APA production</article-title>. <source>Enzyme Microb. Technol.</source> <volume>119</volume>, <fpage>65</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.enzmictec.2018.08.006</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>